Article
Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases.
Rheumatic diseases clinics of North America - 1 Nov 1992
Fathman C G
Abstract excerpt
During the past two decades, investigators have made great inroads in understanding markers of genetic predisposition to the development of rheumatic diseases. An important question that must be addressed by investigators and clinicians is whether this knowledge will ultimately benefit patients, either through genetic counseling or predictions for beneficial therapeutic intervention. This article discusses...
Topics
- CD4 Antigens
- Epitopes
- Genetic Predisposition to Disease
- Humans
- Immunotherapy
- Major Histocompatibility Complex
- Receptors, Antigen, T-Cell
- Rheumatic Diseases
